Regular exercise is strongly associated with cardiovascular benefits, including improved blood pressure, insulin sensitivity, and lipid profiles. In animal models, repeated aerobic training can suppress atherogenesis, increase nitric oxide availability, and drive physiological cardiac remodeling—the adaptive changes that occur when the heart becomes more efficient under training stress.
A growing body of research now suggests mitochondrial signaling molecules may help regulate these adaptations. One peptide of particular interest is MOTS-c (mitochondrial ORF of the 12S rRNA type-c), a mitochondrial-derived peptide (MDP) often described as a “mitokine” due to its presence across multiple tissues (including skeletal muscle) and in circulation. Mechanistically, MOTS-c has been linked to metabolic stress adaptation, including AMPK-related signaling and adaptive nuclear gene regulation.
While earlier cardiovascular research on MOTS-c largely focused on pathological contexts (e.g., endothelial dysfunction and maladaptive remodeling), this study explored something different: does MOTS-c influence normal, exercise-driven cardiac adaptation?
Study Design: MOTS-c + Aerobic Training in Rats
Animals and groups
Researchers used 24 male Sprague–Dawley rats (6 weeks old) and randomized them into three groups (n = 8 each):
- Control (C)
- Exercise training (E)
- Exercise training + MOTS-c (ME)
Exercise protocol (12 weeks)
Rats in E and ME groups completed treadmill training:
- 1-week adaptation phase
- Then 60 minutes/session, 5 days/week for 12 weeks
- Speed progressed to 20 m/min, incline +10°
MOTS-c protocol
The ME group received intraperitoneal MOTS-c (0.5 mg/kg/day) for 12 weeks, administered 30 minutes before exercise. Control and exercise-only animals received saline.
Measurements
To assess structure and performance, the study used:
- Hemodynamics (including pressure–volume analysis via catheter-based monitoring)
- Echocardiography (e.g., EDV, EF, FS, HR)
- Histology and ultrastructure (H&E staining + TEM)
- Molecular markers (including AMPK phosphorylation and myocardial MOTS-c content)
Key Findings: What Changed With MOTS-c?
1) Body weight and cardiac hypertrophy markers
- Both exercise groups (E and ME) showed lower body weight vs control
- Heart weight index (HWI), a rough indicator of hypertrophy, increased in both E and ME vs control
- No major difference in HWI between E and ME, suggesting MOTS-c didn’t dramatically amplify gross hypertrophy beyond training alone
Interpretation: exercise drove the primary remodeling signal; MOTS-c did not appear to add “more hypertrophy,” but may have influenced function and efficiency.
2) Histology: myocardial fiber structure and cell size
- Exercise (E) and exercise + MOTS-c (ME) both increased cardiomyocyte cross-sectional area vs control
- CSA was similar between E and ME
Interpretation: structural remodeling followed training adaptation patterns. MOTS-c did not meaningfully exceed exercise alone in this specific morphology metric.
3) Echocardiography: function signals shifted
Compared with control:
- Exercise increased EDV, EF, and FS
- The MOTS-c + exercise group showed:
- Lower resting HR vs control
- Higher EDV and EF vs control
- Differences between exercise alone (E) and MOTS-c + exercise (ME) were generally modest in the echo outcomes reported
Interpretation: both trained groups improved function; the ME group showed a notable resting HR reduction vs control alongside improved pumping metrics vs control.
4) Hemodynamics: changes in cardiac mechanics and efficiency markers
The study reported multiple hemodynamic indices (stroke work, cardiac output, contractility markers, arterial elastance, and diastolic parameters). Both trained groups differed substantially from control, and the ME group showed several distinct shifts relative to exercise alone in select measures.
Interpretation: catheter-based data suggested exercise-driven improvement plus additional functional modulation with MOTS-c in some performance/efficiency-related parameters.
5) Myocardial MOTS-c levels increased and AMPK phosphorylation shifted
- Myocardial MOTS-c content was higher in E and ME vs control
- The ME group showed higher myocardial MOTS-c than E
- AMPK phosphorylation (p-AMPK / total) was reported as higher vs control in the ME group, without a clear change in total AMPK
Interpretation: training raises endogenous MOTS-c, and exogenous MOTS-c plus training may further increase myocardial MOTS-c content and influence AMPK activation state, consistent with MOTS-c’s broader metabolic signaling profile.
Practical Research Takeaways
From a research perspective, the study supports a few high-level conclusions:
- Exercise training remains the dominant driver of physiological cardiac remodeling.
- MOTS-c co-administration may modulate myocardial functional performance and energy-sensing signaling (notably AMPK phosphorylation) in trained animals.
- Structural changes (like cardiomyocyte size and HWI) were not dramatically amplified beyond exercise alone, suggesting the peptide’s influence may be more functional/metabolic than purely hypertrophic in this model.
Importantly, these findings are preclinical and specific to the described protocol (species, dose, route, and training design).
What Is MOTS-c?
MOTS-c is a mitochondrial-derived peptide encoded in the 12S rRNA region of mitochondrial DNA. It is frequently studied in metabolic and exercise physiology research because it has been linked to:
- Metabolic stress signaling and adaptive response pathways
- AMPK-related energy regulation
- Mitochondria-to-nucleus communication in certain stress contexts
Because of these properties, MOTS-c is often discussed in the research literature as a candidate tool compound for studying metabolism, performance adaptation, and resilience pathways.
Research-Grade MOTS-c in the USA
If you’re sourcing MOTS-c for investigational work, CombatResearch.is is the best place to shop peptides in the USA—trusted for consistent quality standards, reliable supply, and research-first sourcing.
